Cargando…
Daily Supplementation of D-ribose Shows No Therapeutic Benefits in the MHC-I Transgenic Mouse Model of Inflammatory Myositis
BACKGROUND: Current treatments for idiopathic inflammatory myopathies (collectively called myositis) focus on the suppression of an autoimmune inflammatory response within the skeletal muscle. However, it has been observed that there is a poor correlation between the successful suppression of muscle...
Autores principales: | Coley, William, Rayavarapu, Sree, van der Meulen, Jack H., Duba, Ayyappa S., Nagaraju, Kanneboyina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681851/ https://www.ncbi.nlm.nih.gov/pubmed/23785461 http://dx.doi.org/10.1371/journal.pone.0065970 |
Ejemplares similares
-
Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies
por: Coley, William, et al.
Publicado: (2012) -
Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness
por: Rayavarapu, Sree, et al.
Publicado: (2013) -
Effect of the IL-1 Receptor Antagonist Kineret(®) on Disease Phenotype in mdx Mice
por: Benny Klimek, Margaret E., et al.
Publicado: (2016) -
Characterization of Dysferlin Deficient SJL/J Mice to Assess Preclinical Drug Efficacy: Fasudil Exacerbates Muscle Disease Phenotype
por: Rayavarapu, Sree, et al.
Publicado: (2010) -
Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy(2J) Mouse Model of Congenital Muscular Dystrophy
por: Yu, Qing, et al.
Publicado: (2013)